Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 02-2017 | |
| Operating Expenses | 5,814 | 3,973 | 3,499 | 2,082 | 1,938 |
| Operating Income | -5,814 | -3,973 | -3,499 | -2,082 | -1,944 |
| Interest Expense | 1 | 941 | 117 | 84 | -160 |
| Other Income | -612 | 225 | 19 | 100 | -277 |
| Pre-tax Income | -6,426 | -4,689 | -3,596 | -2,066 | -2,061 |
| Net Income Continuous | -6,426 | -4,689 | -3,596 | -2,066 | -1,963 |
| Net Income | $-6,426 | $-4,689 | $-3,596 | $-2,066 | $-1,963 |
| EPS Basic Total Ops | -12.59 | -14.81 | -11.87 | -6.78 | -8.70 |
| EPS Basic Continuous Ops | -12.81 | -14.77 | -11.72 | -6.74 | -8.54 |
| EPS Diluted Total Ops | -12.59 | -14.81 | -11.87 | -6.78 | -8.70 |
| EPS Diluted Continuous Ops | -12.81 | -14.77 | -11.72 | -6.74 | -8.54 |
| EBITDA(a) | $-5,276 | $-3,491 | $-2,930 | $-1,586 | $-1,411 |